Back
Y-mAbs Therapeutics Vs. Mirum Pharmaceuticals Industry Stock Comparison
Buy
84
YMAB
Y-mAbs Therapeutics
Last Price:
15.46
Seasonality Move:
19.38%
Buy
75
MIRM
Mirum Pharmaceuticals
Last Price:
41.98
Seasonality Move:
32.47%
Buy
84
Y-mAbs Therapeutics (YMAB)
is a Buy
Is Y-mAbs Therapeutics a Buy, Sell or Hold?
- The current Y-mAbs Therapeutics [YMAB] share price is $15.46. The Score for YMAB is 84, which is 68% above its historic median score of 50, and infers lower risk than normal.
- YMAB is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
75
Mirum Pharmaceuticals (MIRM)
is a Buy
Is Mirum Pharmaceuticals a Buy, Sell or Hold?
- The current Mirum Pharmaceuticals [MIRM] share price is $42.00. The Score for MIRM is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- MIRM is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
YMAB Stock Price Chart
What is Y-mAbs Therapeutics's stock price today?
-
The Y-mAbs Therapeutics share price today is $15.46
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and YMAB is experiencing buying pressure, which is a positive indicator for future bullish movement.
MIRM Stock Price Chart
What is Mirum Pharmaceuticals's stock price today?
-
The Mirum Pharmaceuticals share price today is $42.00
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MIRM is experiencing slight buying pressure.
YMAB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.39 | Buy |
| Relative Strength Index (14 RSI): | 62.32 | Buy |
| Chaikin Money Flow: | 466556 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.21 - 15.11) | Buy |
| Bollinger Bands (100): | (11.83 - 14.47) | Buy |
MIRM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.4 | Buy |
| Relative Strength Index (14 RSI): | 63.67 | Buy |
| Chaikin Money Flow: | 75051 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (38.64 - 40.54) | Buy |
| Bollinger Bands (100): | (36.44 - 42.04) | Buy |
YMAB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 15.1 | Buy |
| 20-day SMA: | 14.81 | Buy |
| 50-day SMA: | 14.11 | Buy |
| 200-day SMA: | 13.79 | Buy |
| 8-day EMA: | 15.19 | Buy |
| 20-day EMA: | 14.8 | Buy |
| 50-day EMA: | 14.18 | Buy |
| 200-day EMA: | 12.71 | Buy |
MIRM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 40.42 | Buy |
| 20-day SMA: | 39.82 | Buy |
| 50-day SMA: | 39.98 | Buy |
| 200-day SMA: | 32.76 | Buy |
| 8-day EMA: | 40.7 | Buy |
| 20-day EMA: | 40.06 | Buy |
| 50-day EMA: | 39.64 | Buy |
| 200-day EMA: | 34.84 | Buy |
Y-mAbs Therapeutics Earnings Growth & YMAB Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.03 per share, and an increase next year of $0.11 per share.
Mirum Pharmaceuticals Earnings Growth & MIRM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.33 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.71 per share, and an increase next year of $0.88 per share.
Y-mAbs Therapeutics Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Mirum Pharmaceuticals Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||